Kenya: Pfizer Covid Vaccine Has Efficacy of Just 12 Percent? No, Screenshot of Global News Headline Fake

23 June 2022
Africa Check (Johannesburg)
By Taryn Khourie

"Pfizer clinical trial data reveals the company's Covid vaccine has a 12% efficacy rate," reads the headline on what seems to be a screenshot of an article by the Canadian news website Global News, circulating on social media since May 2022.

It shows a generic photo of a row of Covid-19 vaccines with the Pfizer logo behind them.

Text below reads: "Despite claims from Pfizer CEO Albert Bourla and countless public health officials that the efficacy of the vaccine was nearly 100%, the findings of the company's clinical trial data show it was less than 12%."

The Pfizer-BioNTech Covid vaccine is used in at least 179 countries. In South Africa, about 27.7 million doses of the vaccine - first, second and booster shot - have been administered.

But did Global News really publish an article revealing that Pfizer's own data found its vaccine had an efficacy rate of less than 12%? We investigated.

Article 'never published on our site'

A Google search for the screenshot's headline returned no Global News articles. We searched the site itself and again came up empty.

What we did find was a Global News article from November 2020 with the headline: "Pfizer says final results show coronavirus vaccine is 95% effective, no safety concerns."

A Global News spokesperson told Reuters that the site had not published the article. "We can confirm that the headline and caption in question were never published on our site and they are falsely associated with the Global News brand."

The screenshot is fake. But what about the claim about the Pfizer-BioNTech vaccine's efficacy?

Efficacy of 95% - but booster shot still needed

"The Pfizer BioNTech vaccine against Covid-19 has an efficacy of 95% against symptomatic Sars-Cov-2 infection," the World Health Organization (WHO) says. Sars-Cov-2 is the coronavirus that causes Covid-19.

The vaccine is proven safe, the WHO says, and significantly reduces Covid hospitalisations and deaths.

In February the US Food and Drug Administration gave emergency authorisation for the Pfizer-BioNTech vaccine to be given to children aged six month to under four years. The jab has an efficacy rate of 80.3% in this age group.

Yale University in the US explains that while the two-dose vaccine does have an efficacy rate of 95%, its protection wanes over time. So it's important that adults get a third booster shot, which "brings the immune system back to robust level", the university says.

Read the original story, with links and other resources.
Africa Check is a non-partisan organisation which promotes accuracy in public debate and in the media. Twitter @AfricaCheck and www.africacheck.org

Tagged:
Copyright © 2022 Africa Check. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.